INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2007

A review suggests alternate-day fasting may modulate chronic disease risk factors, potentially to an extent similar to calorie restriction.

This review summarizes animal and human evidence regarding alternate-day fasting (ADF) and chronic disease risk compared with calorie restriction (CR). In humans, limited trials reported greater insulin-mediated glucose uptake, higher HDL-cholesterol concentrations, and lower triacylglycerol concentrations, but no effect on fasting glucose, insulin concentrations, or blood pressure, with no human cancer data to date. In animal studies, ADF lowered diabetes incidence, fasting glucose, insulin, total cholesterol, triacylglycerols, heart rate, and blood pressure, improved response to myocardial infarction, and showed decreases in lymphoma incidence, longer survival after tumor inoculation, and lower cell proliferation rates. The authors note that more research is required to establish definitively the consequences of ADF.

Study type
Narrative review of human and animal trials
Who was studied
Humans and animals across multiple reviewed studies (numbers not stated)
What was measured
Risk factors for type 2 diabetes, cardiovascular disease, and cancer

THE PAPER

Alternate-day fasting and chronic disease prevention: a review of human and animal trials.

Varady KA, Hellerstein MK. Am J Clin Nutr, 2007.

PubMed 17616757 ↗DOI 10.1093/ajcn/86.1.7 ↗

Heart & arteriesDiabetes & blood sugarCancerBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.